eHealth mHealth HealthTech innovations - Marketing Santé innovant
43.3K views | +39 today
Follow
 
Scooped by Dominique Godefroy
onto eHealth mHealth HealthTech innovations - Marketing Santé innovant
Scoop.it!

AI is disrupting clinical practice, so how tech is implemented matters

AI is disrupting clinical practice, so how tech is implemented matters | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

As artificial intelligence continues to find its way into clinical workflows, the reaction of healthcare professionals runs the gamut: Some are dubious, some are overly optimistic, some are surely scared the technology could soon make their jobs obsolete.

Each, in their own way, has a valid perspective. Because so much about how AI applications work in healthcare depends on the technology, the algorithms, the quality of the data, the deftness with which the tools are integrated into care processes.

But there's little doubt that when those things are approached in the right way, AI and machine learning have a lot to offer healthcare diagnosis and decision support – even if those insights should be given the proper weight when it comes to developing treatment plans.

Still, plenty of physicians and clinicians have skepticism to spare, if not outright hostility, said Jeff Axt, project manager and systems analyst in the IT department at the Hospital for Special Care in New Britain, Connecticut.

more...
No comment yet.
eHealth mHealth HealthTech innovations - Marketing Santé innovant
Digital, Apps, IoT, devices, AI / DL (...) innovations for Health and Healthcare
Your new post is loading...
Your new post is loading...
Scooped by Dominique Godefroy
Scoop.it!

Your next doctor’s appointment might be with an AI

Your next doctor’s appointment might be with an AI | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

My stomach is killing me!”

“I’m sorry to hear that,” says a female voice. “Are you happy to answer a few questions?”

And so the consultation begins. Where’s the pain? How bad is it? Does it come and go? There’s some deliberation before you get an opinion. “This sounds like dyspepsia to me. Dyspepsia is doctor-speak for indigestion.”

Doctor-speak, maybe, but it’s not a doctor speaking. The female voice belongs to Babylon, part of a wave of new AI apps designed to relieve your doctor of needless paperwork and office visits—and reduce the time you have to wait for medical advice. If you’re feeling unwell, instead of calling a doctor, you use your phone to chat with an AI.

The idea is to make seeking advice about a medical condition as simple as Googling your symptoms, but with many more benefits. Unlike self-diagnosis online, these apps lead you through a clinical-grade triage process—they’ll tell you if your symptoms need urgent attention or if you can treat yourself with bed rest and ibuprofen instead. The tech is built on a grab bag of AI techniques: language processing to allow users to describe their symptoms in a casual way, expert systems to mine huge medical databases, machine learning to string together correlations between symptom and condition.

Babylon Health, a London-based digital-first health-care provider, has a mission statement it likes to share in a big, bold font: to put an accessible and affordable health service in the hands of every person on earth. The best way to do this, says the company’s founder, Ali Parsa, is to stop people from needing to see a doctor.

When in doubt, the apps will always recommend seeking a second, human opinion. But by placing themselves between us and medical professionals, they shift the front line of health care. When the Babylon Health app started giving advice on ways to self-treat, half the company’s patients stopped asking for an appointment, realizing they didn’t need one.

Babylon is not the only app of its kind—others include Ada, Your.MD, and Dr. AI. But Babylon is the front-­runner because it’s been integrated with the UK’s National Health Service (NHS), showing how such tech could change the way health services are run and paid for. Last year Babylon started a trial with a hospital trust in London in which calls to the NHS’s non-­emergency 111 advice line are handled partly by Babylon’s AI. Callers are asked if they want to wait for a human to pick up or download the Babylon-powered “NHS Online: 111” app instead.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Consumerism driving hospitals to break down cybersecurity boundaries

Consumerism driving hospitals to break down cybersecurity boundaries | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Hospitals have spent years implementing firewalls and security controls to establish a perimeter. Now they’re at a crossroads as consumerism and patient experience take hold in healthcare.

First-moving IT and infosec shops, in fact, are already working to build a better patient experience — but doing so requires a new cloud mindset and culture change.

Those are among my takeaways from the HIMSS Security Forum in Boston this week. CISOs and security experts shared experience and insights about where healthcare is going, and what executives need to be thinking about today to make it happen.
Consumerism calls for new cybersecurity

“We’re taking down the perimeter,” Intermountain Healthcare CISO Karl West said.

Already, 75 percent of the system’s physicians conduct a total quarter-million virtual visits every month. What’s more, 80 percent of the data West described as critical to Intermountain is already in the cloud and the rest of it will move there in the next one to two years.

“The future environment we’re striving for is consumer-centric. People want frictionless entry into and out of our system: they want to understand how to navigate and most of them don’t want to go into a hospital,” West said.

The corporate goals of Sentara Healthcare, with patient populations in Virginia and North Carolina, include becoming more customer-centric through a new portal and mobile apps, along with a back-end enterprise data and analytics platform, said Dan Bowden, CISO of Sentara.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

FibriCheck Receives FDA Clearance for its Digital Heart Rhythm Monitor -

FibriCheck Receives FDA Clearance for its Digital Heart Rhythm Monitor - | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
The FDA has approved FibriCheck as a medical smartphone application to become the first FDA approved app for heart rhythm disorders that uses only an optical signal originating from a non-medical device such as a smartphone.

FibriCheck utilises the camera of a smartphone, or the optical sensors of a smartwatch, to detect heartbeats and
derive a heart rhythm. This technique is based on photoplethysmography or PPG for short. By using artificial
intelligence in combination with medical software, FibriCheck is able to carry out an accurate analysis of the heart
rhythm and informs the user and/or the physician about this condition.

The main purpose of FibriCheck is to detect atrial fibrillation, a disorder that affects 1 out of 4 adults and has a fivefold increase for having a cerebrovascular stroke. By using the FibriCheck technology, the user can timely detect
atrial fibrillation and correct therapy can be provided.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

The Advancements That Are Changing Medical Tech

The Advancements That Are Changing Medical Tech | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
When it comes to medical advancements, the skill and ability that medical professions have are supplemented by major improvements in medical technology. These range from major breakthroughs that change the way that we treat major diseases, to innovations that help improve the quality of life for those that have certain health conditions.

However, even with these advancements in place, there are still many different areas where medical technology is needed. For example, some major conditions are still in place, and a growing elderly population is requiring different care in greater volumes. Here are some upcoming tech advancements worthy of note.

If you haven’t been living under a rock, you might be aware that the United States is experiencing a diabetic catastrophe. 1 in 3 children are considered OBESE; contributing much higher rates of diabetes. While some simply continue to have terrible diets as they grow older, many turn to diet to alter their bodies and return to normal insulin production. One of the diets gaining steam is the Ketogenic diet, and studies show that the Type 2 diabetes can actually be reversed.
more...
No comment yet.
Rescooped by Dominique Godefroy from Social Media and Healthcare
Scoop.it!

Doctors Look To Data To Increase Patient Engagement

Doctors Look To Data To Increase Patient Engagement | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

For many reasons, several of which we’ll discuss here, a patient’s full understanding of, and engagement with,their health care experiences are vital for a positive outcome. And today, we have more options than ever for achieving higher levels of interest, patient engagement, and “buy-in” from health care customers. These include data-rich wearables, telemedicine for housebound patients and electronic health records that follow us around as we switch providers or seek treatment from specialists.

 

We’re positively swimming in data. But all that noise stands a good chance of confusing or distracting patients from their ultimate goal of ongoing good health if doctors and patients don’t come to the table together with a plan and a common understanding of which data points are meaningful in context and which are not. 

There’s no doubt anymore: Big data is going to revolutionize the way we administer health care throughout the world and help us achieve financial savings. But as doctors look to leverage modern tools for interacting with and sharing patient health data, there are several factors to remember and several key advantages worth checking out. Here’s a rundown.

Data in Long-Term Treatment for Chronic Diseases

Regrettably, we still lack a cure for many chronic diseases. Therefore, doctors and their patients must instead “manage” these conditions. It’s possible to live a full and active life while undergoing treatment for severe diseases and conditions, but only with the right levels of vigilance and engagement. Patients with chronic illnesses must maintain their motivation, their attention to treatment and medication schedules and their general knowledgeability about their condition.

Chronic diseases are particularly well-suited to data-driven treatment because they come with unique challenges:

  • Maintaining a working knowledge of how the condition and treatments are progressing is vital for patients to keep good morale.
  • Lapses in treatment can add to the overall costs of treatment, which is why vigilant adherence to treatment plans, as laid out by doctors and specialists, is so important.
  • Not every chronic condition requires constant trips to the doctor’s office. In many cases, self-management of these cases is possible, and patients can independently administer medicine and engage with their health outcomes without regular trips to a doctor’s office or exam room.

Working together, doctors and patients can use real-time and historical health data to better understand the individual’s holistic health and draw up bespoke treatment plans for their unique circumstances. One part of the equation involves applying predictive models to anticipate future changes or unexpected turns their health condition might take.


Via Plus91
more...
Rescooped by Dominique Godefroy from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
Scoop.it!

Pharmacie du futur et médicaments sur mesure  #esante #hcsmeufr

Pharmacie du futur et médicaments sur mesure  #esante #hcsmeufr | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
L'innovation dans l'industrie pharmaceutique est transverse à tous les acteurs. Un écosystème qui, poussé par la vague du numérique, se traduit par une élaboration plus rapide des médicaments et une amélioration de la qualité de la prise en charge du patient dès l'officine. Les métiers évoluent, certains naissent, comme le Care Manager, chargé de suivre le patient à l'aide d'un programme de santé personnalisé.

Via Robert Courbé, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

How AI is making its way into pharma and healthcare

How AI is making its way into pharma and healthcare | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Will we see enhancements of AI in pharma and healthcare?

Having read many insightful articles and spoken to several experts on how artificial intelligence (AI) will significantly impact on the healthcare industry, I wanted to add to the conversation. Specifically, in terms of how advances in voice technology and chatbots will not only enhance patient care but also give pharmaceutical companies access to alternative providers and innovative services to support their brands.

Investment facts and forecasts for AI in pharma and healthcare

It’s easy to think that AI in pharma and healthcare is something that “I don’t need to worry about for a while”, “Doesn’t apply to my brand” or “Will be a while before it takes off”. However, if investment is ever a measure of how serious an industry is about making something happen, then the routine use of AI is already here. This is particularly true in the area of analysing big data to identify trends; with the ultimate goal of natural conversations with AI (‘hybrid AI’ systems) just around the corner.
From an NHS funding perspective, the Academic Health Science Networks (AHSN) and SBRI Healthcare partnership has funded 87 companies with a total of approximately £35 million since 2013 in the digital/ICT/mobile solutions category alone. One specific project in this category related to the use of a chatbot/avatar for supporting young people with mental health conditions, which attracted funding of just over £1 million.

According to McKinsey Global Institute, the funding from the private sector is significant, with internal investment in AI by large corporations estimated to be between $18 billion and $27 billion in 2016 alone, while external investment (from venture capitalists, private equity etc) accounted for $8 billion to $12 billion.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Is emotional support part of AI's future in healthcare?

Is emotional support part of AI's future in healthcare? | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
The uses for artificial intelligence have been sprouting up all over the healthcare field, from reading images to automating work flows. Now some researchers are looking to use that technology to move beyond the analytical tasks and move into providing a more human touch.

“There is one view that we can allow these AI [tools] to deal with data and analytics and we let people deal with the caring, and the empathy, and the emotional aspects of care, which I think is absolutely critical,” Cynthia Breazeal, associate professor of media arts and sciences at MIT and director of the Personal Robots Group, said at the Connected Health Conference in Boston this morning. “What if technology is capable of high touch engagement? What if AI was also social and emotionally intelligent?”

As Amazon Echos and Google Homes begin to enter the domestic space, the population that comes into contact with AI is growing. Children and senior citizens alike are are now engaging with the technology, she points out. This could make the technology ripe for new uses and a wider audience.

Breazeal’s lab focuses on machines called social robots.

“For me when I talk about emotional engagement, it’s not just about great user experience with technology,” she said. “It is about deeper human engagement to enable transformative change in people’s lives.”
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Merck & Co picks Nike exec to be digital transformation leader

Merck & Co picks Nike exec to be digital transformation leader | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Merck & Co has appointed Nike’s Jim Scholefield to be its new chief information and digital officer, continuing a trend in pharma to hire in expertise from the consumer world.

Scholefield starts work at the US pharma giant on 29 October and will be responsible for leading Merck & Co's (MSD outside North America) IT and digital strategy, increasingly seen as a vital factor in driving business efficiencies and commercial success.

He will also have oversight of cyber-security – a big issue for the company after a ransomware attack in June 2017 brought the company to a grinding halt.

Scholefield will be part of the company’s executive committee, reflecting how integral the digital transformation drive is to the business.

Currently Nike’s chief information officer, Scholefield led the creation of the sportswear giant’s new enterprise architecture, including the upgrade of critical infrastructure and delivery of state-of-the art cyber-security.

He then championed the digital transformation of Nike, using new technology in order to serve consumers “faster and more personally at scale”. The company launched its customised trainer service several years ago, operating under the slogan “you design it we make it” with a normal turnaround time of 3-5 weeks.

It is this kind of digitally enabled speed and customer focus which the big pharma giants are now all pursuing, as more and more interactions with healthcare professionals go digital.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

An App Store for genomics

An App Store for genomics | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Oklahoma Sen. Elizabeth Warren made headlines this week by publicizing the results of a DNA ancestry test meant to dispel allegations – particularly from President Donald Trump – that her claims of Native American heritage were fabricated. But while her announcement drew mixed opinions from several quarters, it showcased how important a business genetic testing has become and how much it has grown.

That growth raises an interesting question: In a market dominated by the likes of 23andMe, how does a new entrant distinguish itself from the rest of the pack?

Research indicates that genetic testing – particularly to measure susceptibility to disease – is a big business that’s set to get bigger. According to a report in June by Global Market Insights, the global market is expected to exceed $22 billion by 2024, driven in part by interest in testing for early detection and prevention of cancers and genetic diseases. 23AndMe presents an anecdotal case that illustrates that growth: Last March, the Food and Drug Administration approved a test from the company that detects BRCA1/2 mutations to determine the risk of breast cancer, while in July of this year, it signed a four-year drug-discovery partnership with British drugmaker GlaxoSmithKline.

Into this market steps Helix, a personal genomics firm founded in 2015 and headquartered in San Carlos, California, near San Francisco. The company has seen a steady flow of money come in, announcing in June the final close of a $200 million Series B financing led by Tim Draper’s venture capital firm, DFJ, with participation from founding investors Illumina, Warburg Pincus, Sutter Hill Ventures, Kleiner Perkins Caufield Byers and Mayo Clinic, with Singapore’s Temasek closing out the final portion.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Apple and Zimmer Biomet launch 10,000-patient Apple Watch study in hip and knee surgeries

Apple and Zimmer Biomet launch 10,000-patient Apple Watch study in hip and knee surgeries | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

Apple and Zimmer Biomet have begun collaborating on a large clinical study that will use an Apple Watch and iPhone app to help prepare and track patients through hip and knee replacement surgeries—with the goal of adding digital health products and active engagement to a new standard of care.

The multiyear trial, which aims to enroll as many as 10,000 participants, will study Zimmer Biomet’s mymobility app and its impacts on recovery and overall costs, by combining patient-reported feedback with heart rate and movement data collected both pre- and postsurgery.

In a statement, Zimmer Biomet President and CEO Bryan Hanson described the project as “one of the largest evidence-gathering clinical studies in orthopedic history.” The company estimates that more than 1 million knee and hip replacements are performed each year in the U.S., with that number expected to more than triple in the next two decades.

The app will remind patients to complete their assigned exercises and deliver educational guidance directly from the watch, with content chosen and prescribed by their surgeon.

In addition, a HIPAA-secure messaging client will allow providers to send texts, pictures or videos to patients to check up on their progress, or answer questions without scheduling an appointment.

“We believe one of the best ways to empower consumers is by giving them the ability to use their health and activity information to improve their own care,” said Jeff Williams, Apple’s chief operating officer.

“We are proud to enable knee and hip replacement patients to use their own data and share it with their doctors seamlessly, so that they can participate in their care and recovery in a way not previously possible through traditional in-person visits,” Williams said.

more...
No comment yet.
Rescooped by Dominique Godefroy from WEARABLES - INSIDABLES - IOT - CONNECTED DEVICES - QUANTIFIEDSELF
Scoop.it!

DFree, a smartphone-connected wearable for incontinence, launches in US  #esante #hcsmeufr

DFree, a smartphone-connected wearable for incontinence, launches in US  #esante #hcsmeufr | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

San Diego-based Triple W has launched a new wearable connected health monitor in the United States, focused on urinary incontinence. The sensor, called DFree, uses an ultrasound sensor to monitor changes in bladder size. Then proprietary algorithms translate that data into information about when a user should head to the bathroom.

 

“DFree is designed to help individuals with incontinence improve quality of life and enable independence, as well as help reduce the burden for the caregivers,” Atsushi Nakanishi, president and CEO of Triple W, said in a statement. “Whether you want to attend a concert, enjoy an afternoon with your grandkids or help a senior parent or loved one who needs extra time to travel from one place to another — you don’t have to worry about finding a bathroom on time.”

 

Why it matters

Incontinence is a widespread but underreported problem, because of the social stigmas involved. The NIH estimates it affects 500 million people worldwide and US retail sales of adult diapers totaled $2 billion in 2016. That market is only growing as baby boomers age.

Triple W’s product could offer an alternative to diapers or pads for some adults. It’s been in use in senior care facilities in Japan and Europe since 2017, the company says.


Via Florian Morandeau, Lionel Reichardt / le Pharmageek
more...
Florian Morandeau's curator insight, October 17, 1:33 AM

This mHealth sensor, called DFree, uses an ultrasound sensor to monitor changes in bladder size.

Scooped by Dominique Godefroy
Scoop.it!

Novartis lance des laboratoires d’innovation en faveur de la santé numérique

Novartis lance des laboratoires d’innovation en faveur de la santé numérique | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Novartis a lancé un réseau de laboratoires d’innovation en matière de santé digitale, baptisé Novartis Biome, pour accélérer son évolution numérique. La société pharmaceutique suisse va également développer une série d’initiatives qui, selon elle, sont conçues pour fournir une rampe d’accès aux start-up qui souhaitent travailler avec elle.

Novartis Biome, dont le premier laboratoire d’innovation est basé à San Francisco, a été cofondé par son directeur général Mohanad Fors et le directeur de l’innovation et de la stratégie Robin Roberts. Selon ce dernier, l’idée est de donner un nouvel élan à l’écosystème des technologies de la santé et de définir une rampe d’accès pour collaborer avec Novartis.


Une solution contribuant à collaborer avec les start-up du secteur

Il est clair que la grande majorité des technologies innovantes ne proviendront pas des grandes sociétés pharmaceutiques. En collaborant avec les start-up et des innovateurs, il est possible de créer quelque chose d’audacieux, durable et évolutif.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

3 Ways AI Is Changing Healthcare

3 Ways AI Is Changing Healthcare | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Making Health Care Human Again

THE CURRENT U.S. HEALTH CARE PICTURE is pretty bleak: more than 12 million serious diagnostic errors each year, a third of the $3.6 trillion spent attributed to waste, reduction in life expectancy for what will be three years in a row (which is unpre­cedented), and peak levels of physician burnout, depression, and suicide. That’s all happening at a time when there is more medical data per individual than ever, imagined with wearable sensor physiology, scan anatomy (above), DNA sequencing, gut microbiome biology, just to name a few layers. Enter deep-learning A.I., with neural networks that will impact every type of clinician, from helping to accurately read scans, slides, skin lesions, eyegrounds, and more, to health systems, promoting the use of remote monitoring that ultimately obviates the need for regular hospital rooms, and at the consumer level, by providing a virtual medical coach to better manage or even prevent diseases. It’s still early in the integration of A.I. into medical practice, with far more hype than validation. But it’s our best shot to deal with all of the formidable challenges: to use the wealth of data to reduce errors and waste, and the gift of time to markedly improve the clinician-patient relationship.
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Philips will challenge tech giants to bring blockchain to healthcare

Philips will challenge tech giants to bring blockchain to healthcare | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

How far can you trust the institutions and organizations that hold your sensitive medical information?

Earlier this month, the Canadian government fined the manager of a pharmacy for using the provincial Drug Information System to snoop on the confidential medical history of friends, family, and coworkers. A few weeks earlier, the Orlando Orthopaedic Center reported that a misconfiguration in its servers resulted in the exposure of more than 19,000 patient records for about two months.

Health-related data breaches are among the most damaging security incidents, and they happen often and everywhere. But what makes the healthcare industry unique is the degree to which internal actors are responsible for threats. “Healthcare is the only industry in which internal actors are the biggest threat to an organization,” found a recent Verizon study.

Part of the challenges of securing health data has to do with how fragmented the industry is. Take medical research. Every study can possibly involve hundreds of institutions, thousands of researchers, and the health information of millions of people. When sensitive health data changes multiple hands in the process of medical research, there are many ways things can go wrong; data breaches and the illegal use and monetization of personal data being two of the most obvious.

The fear of running into troubles like these seriously limits innovation and expansion of medical research activity. Researchers at Philips are exploring the use of blockchain in establishing trust and accountability across medical research ecosystems. This will hopefully help prevent security incidents and lay the ground for improving innovation and cooperation in ways that weren’t possible before.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Digital Marketing Dominates Healthcare Advertising

Digital Marketing Dominates Healthcare Advertising | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

As marketing evolves across all industries, companies are turning to digital approaches to stay in front of consumers. Here are the top three digital healthcare advertising trends to be aware of.

As marketing evolves, across all industries, companies are turning to more digital approaches to stay in front of consumers. Digital marketing spend has been the highest of all time, with healthcare-related companies spending over $2.5 billion on marketing, a number expected to increased to $4 billion by 2020.

Despite the large annual expenditure, healthcare-related companies still only account for 3% of the digital marketing spend, significantly less than the retail companies that continue to dominate this arena. Historically, wellness providers and hospital systems leveraged television, radio, and billboards as the preferred channels for their healthcare advertisements. However, in 2017, marketing researchers found that a seismic shift is underway and redefining how healthcare providers are positioning their brand in front of their target audiences.

In fact, 44% of marketing spend on health-related products and services is being dedicated to mobile-specific and digital platforms. Television advertising spend has dropped to less than 33% and is expected to continue to decline, as marketing returns on television placements seem to no longer warrant their investment.

Three notable digital marketing trends are quickly emerging as healthcare providers pivot to reach consumers where they are on the platforms they already use.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Embleema : quand le futur Health Data Hub français envisage la blockchain

Embleema : quand le futur Health Data Hub français envisage la blockchain | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
La Sécurité Sociale discutée à l’heure de la fièvre Blockchain – Je ne vais pas vous raconter ma vie, mais pour contextualiser très vite, je traîne mes guêtres à l’occasion dans le milieu médical, du fait de mon statut de thérapeute de santé. Je suis aussi, sur le principe, allergique au Blockchain Bullshit. Pour autant, ne pas y voir d’intérêt immédiat ne dispense pas de rester curieux, puisqu’il semblerait bien que les gouvernements envisagent en premier lieu ce modèle de services publics tokenisés.


Mise en contexte

Et curieux, je l’ai été quand j’ai vu passer les premières références à une potentielle application blockchain dans le domaine de la Santé, début janvier. À l’origine de cette initiative, le consortium Embleema. Mais quésaco ? Si vous êtes comme moi, là, vous êtes probablement en train de vous dire que c’est encore un groupe de développeurs étranges qui va vous demander vos précieuses cryptos dans un ICO louche pour prétendument aider les pauvres patients malades.
Moi-même, j’étais un peu dubitatif au départ, voyez…

Comme je vous en parlais, Renan et moi avons profité du Paris Blockchain Day récent pour rencontrer certains entrepreneurs de la sphère crypto. Et parmi ces derniers, nous avons pu croiser des représentants de ce consortium, qui profitait de l’événement pour s’afficher et organiser une soirée débat avec des représentants du milieu médical français, du gouvernement et d’experts e-santé le même-jour. Conférence où nous nous sommes donc rendus, puisque nous souhaitions tirer un peu tout cela au clair.

Cassons le suspense d’office : non, le Ministère de la Santé n’envisage pas de déployer une Sécurité Sociale numérique blockchainisée sur la blockchain Bitcoin. Voilà, c’est dit. Dans le cas précis de la solution de stockage de dossiers médicaux numériques sur la blockchain et de marché secondaire des données de santé développée par Embleema, le système prendrait place sur une Blockchain Ethereum privée, avec cependant un switch prévu dans l’avenir sur une infrastructure plus rapide, de type EOS.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Ces dix Français qui dominent la santé mondiale

Ces dix Français qui dominent la santé mondiale | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

On sait que la France a une solide tradition d'excellence en mathématiques. On sait aussi que Paris est devenu un hub technologique qui rivalise avec Londres et Berlin - le Salon VivaTech l'illustre chaque printemps. On le sait moins, mais dans le domaine de la recherche médicale aussi, des Français sont à la pointe. La preuve en dix portraits.

Immunothérapie, microbiote, thérapie génique, épigénétique, « digital therapeutics » : publique ou privée, la recherche française est en pointe dans le combat contre les grandes maladies du siècle, diabète, cancer, Alzheimer… Les découvreurs d'aujourd'hui sont les héritiers d'une longue histoire d'excellence qu'on peut faire remonter à Louis Pasteur dans les vaccins, et qui s'étend jusqu'au Nobel de médecine Jules Hoffmann, récompensé par la prestigieuse académie en 2011 pour ses travaux en immunologie.

 

L'Hexagone est le seul pays à placer aux côtés des Etats-Unis, grâce à l'Inserm et l'AP-HP, des centres de recherche dans le Top 10 mondial établi par le Boston Consulting Group. « Grâce à notre science multidisciplinaire (informatique, mathématiques, robotique, etc., NDLR), la France reste très performante », souligne Maryvonne Hiance, la présidente de l'association professionnelle France Biotech. Ce qui ne veut pas dire que cette excellence n'est pas menacée.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

[Tribune] La France connectée au Hub Européen, première étape vers la sécurisation de la chaîne de distribution des médicaments

[Tribune] La France connectée au Hub Européen, première étape vers la sécurisation de la chaîne de distribution des médicaments | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

A partir du 9 février 2019, pour lutter contre les médicaments falsifiés, plus aucun étui de médicaments délivrés sur ordonnance ne pourra circuler sur le territoire européen sans être sérialisé, c’est à dire marqué et tracé à l’unité pour compléter la traçabilité au lot déjà existante. L'analyse de Christophe Devins, co-fondateur et PDG d’Adents.

L’Europe représente un des plus gros marchés mondiaux pour la contrefaçon de médicaments. La mise en œuvre de cette nouvelle traçabilité, imposée par la Directive Européenne 2011/62/UE, est une révolution qui ne dit pas son nom pour l’industrie pharmaceutique. Concrètement les datamatrix (codes-barres à deux dimensions) figurant sur les boîtes de médicaments devront contenir, en plus des informations habituelles (code identifiant de présentation, numéro de lot, date de péremption), un numéro de série spécifique à la boîte concernée. Ceci en plus d’un dispositif de contrôle d’inviolabilité.

L’impact sur les organisations, la nécessité d’implémenter de nouveaux process industriels, la mise en place de bases de données interconnectées entre les laboratoires, leurs façonniers et partenaires logistiques jusqu’aux points de dispensation que sont les pharmacies et hôpitaux créent des challenges importants pour l’ensemble de ces acteurs.

La création et la gestion de ces milliards de numéros uniques qui devront être stockés, indexés, échangés, vérifiés mènent l’industrie pharmaceutique vers le challenge du big data. Certains acteurs sont prêts, d’autres beaucoup moins.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

AI in healthcare: Can AI solve the health tech puzzle of new drug discovery?

AI in healthcare: Can AI solve the health tech puzzle of new drug discovery? | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
R&D is critical in the world of healthcare, but it is also tricky; progress is slow, and further progress is hampered by the way different researchers and drug developers work in silos, data is kept secret, locked away from the rest of the world. Can AI in healthcare come to the rescue?

Vas Narasimhan, CEO at Novartis, recently warned of a problem finding new data. In an interview with Bloomberg, he said that this lack of data has in part caused his initial enthusiasm for AI to turn more cautious.

This may yet prove to be the single biggest hurdle in applying AI in healthcare to help find cures to new diseases, extend life, and improve the quality of life.

Julien de Salaberry, CEO of Galen Growth Asia, a Singapore based organisation that is creating a $70 billion health tech ecosystem across Asia put it this way: “AI as a tool to aid research is still largely hype.”

He explains: “Its use is hampered largely because of the way data is held in silos and the interoperability of data is not there — everybody is hoarding data as if it was gold, and so the academic centres don’t speak to each other, the researchers don’t speak to each other, either.

“Everyone is building data, it’s growing faster than any other commodity on the planet, but no one is really sharing that data.”
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Exclusive: Remedy launches screening tool to uncover undiagnosed chronic illness

Exclusive: Remedy launches screening tool to uncover undiagnosed chronic illness | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

San Francisco-based startup Remedy has launched an AI-powered tool to screen patients for their risk of chronic illness.

Dubbed Remedy Sentinel, the new platform aids the company’s care coordinators to assess and identify both clinical and sociodemographic risk factors for chronic illnesses like diabetes, COPD, chronic kidney disease, depression and congestive heart failure.

“We’re training our algorithm to think like a physician to empower non clinical staff on how to get information from a patient,” said CEO William Jack in a phone interview. “There’s important information that is generated outside of the four walls of the clinic that aren’t captured in EMR and claims data.”

According to Jack, traditional diagnostic and screening methods don’t delve deeply enough into the lifestyle and social factors that contribute to the risk for chronic disease. Alongside disease diagnosis, the company helps connect patients to resources to help manage their condition more effectively.

Remedy is also launching an associated pro-bono service that allows patients with providers or health plans not using the platform to apply for their own chronic disease screenings.

The company’s origins date back to the issues when Jack was misdiagnosed for his epilepsy and wanted to determine a better way to utilize more up-to-date data into the diagnostic process.

By targeting chronic disease, the company is focusing on the main cost drivers in the healthcare system and hoping to highlight potential health risks for patients before they get to a crisis point. An oft-cited statistic is that five percent of patients drive 95 percent of healthcare costs.

Based on an analysis of CDC and AHRQ data, the company claims that tens of millions of Americans are at potential risk of a chronic illness that they are unaware of, including 70 percent of patients with chronic kidney disease and 20 percent of patients with diabetes.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Foundation Medicine, Novartis partner up on companion diagnostics in oncology

Foundation Medicine, Novartis partner up on companion diagnostics in oncology | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

A company focused on next-generation sequencing-based diagnostics is partnering with a large Swiss drugmaker.

Foundation Medicine, based in Cambridge, Massachusetts, said Wednesday that it had formed a collaboration with Novartis. The development and commercialization partnership will involve Novartis using the diagnostics maker’s comprehensive genomic profiling assay, FoundationOne CDx, to develop companion diagnostics for its cancer drugs. FoundationOne CDx received Food and Drug Administration approval in November 2017. Fellow Swiss drugmaker Roche acquired the remaining shares of Foundation Medicine that it didn’t already own in June.

“It is imperative that we collaborate with all of the key stakeholders in oncology to accelerate patient access to personalized medicine,” Foundation Medicine Chief Business Officer Melanie Nallicheri said in a statement.

The partnership will also enable Foundation to expand into markets outside the US. In Japan, it is working with drugmaker Chugai and has submitted FoundationOne CDx for regulatory approval with the Ministry of Health, Labour and Welfare. The company said the move would allow cancer patients in Japan to have access to approved targeted therapies, immunotherapies and clinical trials.

more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

Virtual reality for stroke patients one step closer thanks to £400k funding

Virtual reality for stroke patients one step closer thanks to £400k funding | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
A partnership involving an NHS hospital in Chester has received more than £400,000 in funding so it can explore the possibility of using virtual reality (VR) to help stroke patients.

The University of Chester’s medical graphics team and the stroke department at the Countess of Chester Hospital believe VR can be used to help people following a stroke.

In particular, the organisations are exploring how a VR headset could be used to give patients the ability to practice and relearn daily activities, such as putting bread into a toaster.

A funding grant of £453,000 has been awarded to the project from the government’s Digital Health Technology Catalyst (DHTC) programme.

Nigel John, from the University of Chester, said: “Our aim is to reduce the duration and cost of long-term care by enabling intensive rehabilitation both in hospital and in the home, using affordable technology. The VR stroke programmes will adapt to each user’s needs and can be operated with minimal supervision, meaning they do not need to rely on family and carers.

“Patients will be able to measure how well their cognitive abilities are improving, building confidence in their ability to perform everyday tasks and reducing the psychological trauma often associated with the condition.”
more...
No comment yet.
Scooped by Dominique Godefroy
Scoop.it!

« Faites confiance aux patients ! » Quelle nouveauté pour quelle transformation en France ? ExpériencePatient.fr lance son 1er baromètre

« Faites confiance aux patients ! » Quelle nouveauté pour quelle transformation en France ? ExpériencePatient.fr lance son 1er baromètre | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it

#faitesconfianceauxpatients

Leur expérience va transformer nos services de santé. Apprendre à recueillir et analyser cette expérience devient un enjeu stratégique pour répondre aux besoins des personnes et orienter les priorités des professionnels. » Qu’est-ce qui se cache derrière le slogan prometteur et méritant de l’Institut Français Expérience Patient ?

Pour y répondre, l’institut de l’Expérience Patient, fondé par Amah KOUEVI, a organisé le 4 octobre 2018 une rencontre à l’auditorium de cardiologie de la Pitié Salpétrière, sur le thème :
« L’expérience patient made in USA, un exemple à suivre ? »

Pour compléter son diaporama en ligne, et diffuser son appel « faites confiance aux patients », je propose de mettre en perspective les exposés et retours de la salle en quatre étapes :

- partir de la définition de l’expérience patient, pour mieux la comprendre et préciser : expérience patient, de quoi parlons-nous ?
- éclairer la dynamique internationale en route : quelle est donc la nouveauté de la nouveauté expérience patient ?
- observer comment elle se déploie aux US, notamment à la Cleveland Clinic, 2ème meilleur hôpital du pays : patient first, medical second
- voir ce que nous disent ces modèles américains issus d’une culture médicale

more...
No comment yet.
Rescooped by Dominique Godefroy from PATIENT EMPOWERMENT & E-PATIENT
Scoop.it!

Plateforme de signalement des effets indésirables : un premier bilan  #esante #hcsmeufr

Plateforme de signalement des effets indésirables : un premier bilan  #esante #hcsmeufr | eHealth mHealth HealthTech innovations - Marketing Santé innovant | Scoop.it
Il y a un an, le ministère de la santé mettait en place la plateforme signalement-sante.gouv.fr à destination des patients, des consommateurs et des professionnels de santé pour « renforcer la vigilance en matière de sécurité sanitaire et simplifier les démarches de signalement ».
 
Elle permet de déclarer des événements indésirables liés aux médicaments, aux dispositifs médicaux, aux « produits de la vie courante », aux actes de soin, aux produits de tatouage, aux cosmétiques, aux compléments alimentaires et enfin aux substances psychoactives légales ou illégales (en dehors de l’alcool et du tabac).
 
Ce premier anniversaire a été l’occasion pour la Direction générale de la santé (DGS) d’établir un premier bilan.
 
Au total, 85 % des signalements sont le fait de non-professionnels de santé et 45 000 signalements ont été recensés. Cependant, la quasi-totalité des signalements d’événements indésirables graves associés à des soins proviennent d’établissements de santé.
 
« La pharmacovigilance et la matériovigilance représentent respectivement 90 % et 5 % des signalements chez les usagers, alors que les professionnels de santé utilisent principalement le portail pour signaler des cas de pharmacovigilance (40 %), des évènements indésirables graves associés à des soins (28 %) et des cas de matériovigilance (14 %) » précise la DGS qui souligne que « le portail s’avère fortement utilisé par les usagers et constitue un réel élément de démocratie sanitaire ».

Via Lionel Reichardt / le Pharmageek
more...
No comment yet.